Cargando…

AB083. Does concomitant testosterone replacement improve the response of tadalafil 5 mg once daily in men with lower urinary tract symptoms?

OBJECTIVES: Recently, tadalafil was found to be effective for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Testosterone (T) regulates nitric oxide synthase and is necessary to achieve an optimum response to PDE5 inhibitors. In the present study, we de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Nam Cheol, Park, Hyun Jun, Moon, Du Geon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842499/ http://dx.doi.org/10.21037/tau.2016.s083

Ejemplares similares

The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis
por: Lee, Sung Won, et al.
Publicado: (2014)

Serum High-Sensitivity C-Reactive Protein Levels and Response to 5 mg Tadalafil Once Daily in Patients With Erectile Dysfunction and Diabetes
por: Lee, Jung Woo, et al.
Publicado: (2013)

Efficacy and Safety of 12-week Monotherapy With Once Daily 5 mg Tadalafil for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: Evidence-based Analysis
por: Cui, Jianwei, et al.
Publicado: (2021)

AB167. Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction
por: Cui, H, et al.
Publicado: (2014)

Efficacy and Safety of Tadalafil 5 mg Administered Once Daily in Korean Men with Erectile Dysfunction: A Prospective, Multicenter Study
por: Kang, Dong Hyuk, et al.
Publicado: (2010)

Once-daily 5 mg tadalafil oral treatment for patients with chronic prostatitis/chronic pelvic pain syndrome
por: Benelli, Andrea, et al.
Publicado: (2018)

A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
por: Washington, Samuel L, et al.
Publicado: (2010)

Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives
por: Costa, Pierre, et al.
Publicado: (2009)

Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction
por: Karabakan, Mehmet, et al.
Publicado: (2017)

Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post-Marketing Surveillance Study
por: Won, Ji Eon, et al.
Publicado: (2018)

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
por: Falk, Jeremy A, et al.
Publicado: (2010)

Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
por: Iacono, Fabrizio, et al.
Publicado: (2012)

Role of application of tadalafil 5 mg once-daily (≥6 months) in men with erectile dysfunction from six randomized controlled trials
por: Ma, Jiajia, et al.
Publicado: (2020)

Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases
por: Brock, Gerald, et al.
Publicado: (2016)

Testosterone Replacement Alone for Testosterone Deficiency Syndrome Improves Moderate Lower Urinary Tract Symptoms: One Year Follow-Up
por: Ko, Young Hwii, et al.
Publicado: (2013)

AB098. Can concomitant dutasteride reduce the effect of testosterone replacement therapy in men with late-onset hypogonadism? A 24-week, randomized, parallel study
por: Park, Hyun Jun, et al.
Publicado: (2016)

Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease
por: Dell’Atti, Lucio
Publicado: (2015)

Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities
por: Hatzichristou, Dimitrios, et al.
Publicado: (2015)

AB71. Testosterone and nocturia
por: Moon, Du Geon
Publicado: (2014)

AB083. Anatomical landmarks for minimally invasive radical prostatectomy
por: Hong, Sung-Hoo
Publicado: (2015)

AB033. Testosterone and nocturia
por: Ahn, Sun Tae, et al.
Publicado: (2018)

The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up
por: Seo, Young Eun, et al.
Publicado: (2014)

The Ideal Goal of Testosterone Replacement Therapy: Maintaining Testosterone Levels or Managing Symptoms?
por: Moon, Du Geon, et al.
Publicado: (2019)

Efficacy and Safety of Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: A 2-Year Follow-Up
por: Kim, Soodong, et al.
Publicado: (2018)

Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms
por: Lee, Min Ho, et al.
Publicado: (2021)

AB083. Abnormal white matter microstructural in lifelong premature ejaculation identified by tract-based spatial statistical analysis
por: Gao, Ming, et al.
Publicado: (2017)

Evolution of Guidelines for Testosterone Replacement Therapy
por: Park, Hyun Jun, et al.
Publicado: (2019)

Erratum: Acknowledgments. The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up
por: Seo, Young Eun, et al.
Publicado: (2014)

Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
por: AbdelRazek, Mostafa, et al.
Publicado: (2022)

AB19. Testosterone replacement therapy: how safe is it?
por: Goldenberg, Larry
Publicado: (2014)

AB04. Novel approaches for testosterone replacement therapy
por: Burnett, Arthur L. (Bud)
Publicado: (2014)

Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial
por: Sebastianelli, Arcangelo, et al.
Publicado: (2019)

Efficacy and safety of low-intensity shockwave therapy plus tadalafil 5 mg once daily in men with type 2 diabetes mellitus and erectile dysfunction: a matched-pair comparison study
por: Verze, Paolo, et al.
Publicado: (2019)

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis
por: Babu, P Ravindra, et al.
Publicado: (2017)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
por: Fleischmann, Roy, et al.
Publicado: (2008)

Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction
por: Jang, Se Won, et al.
Publicado: (2022)

AB004. Contemporary perspectives on testosterone replacement therapy (TRT)
por: Hellstrom, Wayne J. G.
Publicado: (2015)

AB173. Effect of testosterone replacement therapy on lipid profile in the patients with testosterone deficiency syndrome
por: Han, Kyung-Sik, et al.
Publicado: (2014)

Effect of Testosterone Replacement Treatment in Testosterone Deficiency Syndrome Patients with Metabolic Syndrome
por: Jeong, Seung Min, et al.
Publicado: (2011)

Correction: Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction
por: Jang, Se Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mh7mshs8k525j0oelp0onqkptc